Intravitreal therapy for the management of diabetic retinopathy:A concise review  

作　　者：Atul Arora Arvind K Morya Parul C Gupta Nitin K Menia Prateek Nishant Vishali Gupta 

机构地区：[1]Teleophthalmology,Postgraduate Institute of Medical Education and Research,Chandigarh 160012,Punjab,India [2]Department of Ophthalmology,All India Institute of Medical Sciences,Hyderabad 508126,Telangana,India [3]Department of Ophthalmology,Post Graduate Institute of Medical Education&Research,Chandigarh 160012,Punjab,India [4]Department of Ophthalmology,All India Institute of Medical Sciences,Vijaypur 180001,Jammu and Kashmīr,India [5]Department of Ophthalmology,ESIC Medical College,Patna 801103,Bihār,India

出　　处：《World Journal of Experimental Medicine》2024年第4期104-119,共16页世界实验医学杂志（英文）

摘　　要：Diabetic retinopathy(DR)is a serious microvascular complication of diabetes mellitus and may result in irreversible visual loss.Laser treatment has been the gold standard treatment for diabetic macular edema and proliferative diabetic retinopathy for many years.Of late,intravitreal therapy has emerged as a cornerstone in the management of DR.Among the diverse pharmacotherapeutic options,anti-vascular endothelial growth factor agents have demonstrated remarkable efficacy by attenuating neovascularization and reducing macular edema,thus preserving visual acuity in DR patients.

关 键 词：Diabetic retinopathy Intravitreal therapy Anti-vascular endothelial growth factor Macular edema Proliferative diabetic-retinopathy 

分 类 号：R774.1[医药卫生—眼科] R587.1[医药卫生—临床医学]